Evaluation of urinary 8-hydroxy-2-deoxyguanosine level in experimental Alzheimer’s disease: Impact of carvacrol nanoparticles

The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials

(2016) C. Groot et al.   AGEING RESEARCH REVIEWS

Antidiabetic assessment; in vivo study of gold and core-shell silver-gold nanoparticles on streptozotocin-induced diabetic rats

(2016) Th. I. Shaheen et al.   BIOMEDICINE & PHARMACOTHERAPY

Late-life Cognitive Activity and Dementia

(2016) Gautam Sajeev et al.   EPIDEMIOLOGY

Protective Effect of Selenium Against Aluminum Chloride-Induced Alzheimer’s Disease: Behavioral and Biochemical Alterations in Rats

(2015) B. V. S. Lakshmi et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease

(2015) Bruno Fonseca-Santos et al.   International Journal of Nanomedicine

Aggravation of Alzheimer's disease due to the COX-2-mediated reciprocal regulation of IL-1β and Aβ between glial and neuron cells

(2014) Pu Wang et al.   AGING CELL

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

(2014) Jeffrey L Cummings et al.   Alzheimers Research & Therapy

Carvacrol: From Ancient Flavoring to Neuromodulatory Agent

(2013) Margherita Zotti et al.   MOLECULES

Blood markers of oxidative stress in Alzheimer's disease

(2012) Alice Skoumalová et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats

(2011) Subramaniyan Jayakumar et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Antioxidant and Antiacetylcholinesterase Activities of Some Commercial Essential Oils and Their Major Compounds

(2011) Smail Aazza et al.   MOLECULES

Estrous cycle affects the neurochemical and neurobehavioral profile of carvacrol-treated female rats

(2011) L. Trabace et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Carvacrol, a component of thyme oil, activates PPARα and γ and suppresses COX-2 expression

(2009) Mariko Hotta et al.   JOURNAL OF LIPID RESEARCH

Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′-deoxyguanosine in the CSF of patients with Alzheimer’s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process

(2009) Chiaki Isobe et al.   JOURNAL OF NEUROLOGY

Neurobiology ofAlzheimer′s disease

(2009) E Mohandas et al.   Indian Journal of Psychiatry

Cyclooxygenase-1 and -2 in the Different Stages of Alzheimers Disease Pathology

(2008) J. Hoozemans et al.   CURRENT PHARMACEUTICAL DESIGN